Michael Redard
2019
In 2019, Michael Redard earned a total compensation of $1M as Chief Financial Officer at Cure Pharmaceutical Holding Corp..
Compensation breakdown
| Option Awards | $925,289 |
|---|---|
| Salary | $106,893 |
| Total | $1,032,182 |
Redard received $925.3K in option awards, accounting for 90% of the total pay in 2019.
Redard also received $106.9K in salary.
Rankings
In 2019, Michael Redard's compensation ranked 9,143rd out of 13,971 executives tracked by ExecPay. In other words, Redard earned more than 34.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,143 out of 13,971 | 35th |
Division Manufacturing | 3,664 out of 5,695 | 36th |
Major group Paper And Allied Products | 78 out of 99 | 21st |
Industry group Converted Paper And Paperboard Products, Except | 22 out of 32 | 31st |
Industry Plastics, Foil, and Coated Paper Bags | 10 out of 13 | 23rd |
Source: SEC filing on August 7, 2020.
Redard's colleagues
We found three more compensation records of executives who worked with Michael Redard at Cure Pharmaceutical Holding Corp. in 2019.